BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3441869)

  • 1. [Some problems of the therapy of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1987; 59(11):66-71. PubMed ID: 3441869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Sheveleva LA
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS; Makurov AI
    Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
    [No Abstract]   [Full Text] [Related]  

  • 5. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
    Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
    Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
    Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
    Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment results in various morphological patterns of glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1984; 56(9):97-101. PubMed ID: 6515557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of membranous glomerulonephritis].
    Stavskaia VV; Riabov SI
    Ter Arkh; 1985; 57(6):74-8. PubMed ID: 4071419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors influencing the results of chronic glomerulonephritis treatment].
    Riabov SI; Stavskaia VV; Chistova EK; Ashkinazi RI; Zaitseva NI; Kravchenko NP; Mozgovaia AN; Sashurina SN
    Klin Med (Mosk); 1997; 75(2):38-42. PubMed ID: 9157214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of the clinical course of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Klin Med (Mosk); 1996; 74(1):17-20. PubMed ID: 8648997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-laboratory pattern and effectiveness of glucocorticoid therapy of patients with primary diffuse mesangioproliferative glomerulonephritis].
    Diadyk AI; Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Kobets VG
    Ter Arkh; 1987; 59(8):35-7. PubMed ID: 3686443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of primary chronic glomerulonephritis].
    Risler T; Braun N; Erley CM
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
    Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
    Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [State of the blood prekallikrein-kallikrein system in patients with glomerulonephritis as affected by pathogenetic therapy].
    Petrun' NM; Pyrig LA; Krimkevich EI
    Ter Arkh; 1985; 57(6):84-6. PubMed ID: 3852551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic glomerulonephritis with cytostatics].
    Tareeva IE; Gordovskaia NB; Gladskikh OP; Ivanov AA; Krasnova TN
    Ter Arkh; 1989; 61(6):9-14. PubMed ID: 2799726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.